In several in vitro model systems, including mouse neurons (TIA-1 mutations) and fibroblasts derived from patients with sporadic ALS mutations, the authors showed that NEDP1 inhibition (delivery of NEDP1 nanobodies) accelerated the elimination of ALS-related aggregates [112]. The gene discussed is SENP8; the disease is amyotrophic lateral sclerosis.